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Epidemiology of idiopathic glomerular disease: a prospective study. In
this study incidence rates of idiopathic glomerular disease in 1.5 X 106
Dutch adults between 16 and 65 years of age were determined, as well
as the prevalence of these diseases in terms of indication for renal
biopsy. The study was conducted between 1978 and 1985; indications
for renal biopsy in decreasing hierarchical order were recently discov-
ered uremia, nephrotic syndrome, chronic hematuria of less than two
years duration with or without proteinuria or disturbed renal function,
and chronic proteinuria of less than two years duration, of unknown
origin. The main findings are fourfold. The incidence of IgA nephrop-
athy and thin glomerular basal membrane lesions was high, 19 and 13
per 106 adults respectively, and the prevalence in patients biopsied
because of nort-azotemic chronic hematuria was 31% and 22%, respec-
tively. In the normotensive non-azotemic adults biopsied because of
chronic, mild proteinuria the prevalence of focal segmental glomerular
sclerosis and vascular hyalinosis was both 41%. Of the patients biopsied
because of nephrotic syndrome the prevalence of membranoprolifera-
tive glomerulonephritis (5%) was low, as was the incidence (less than 2
per 106 adults per year). Finally, the prevalence of diffuse sclerosing
glomerulonephritis was 25% in patients biopsied because of uremia.
This study is useful for the differential diagnosis of idiopathic glomer-
ular disease.
For the differential diagnosis of uremia, nephrotic syndrome
and hematuria of unknown origin, knowledge of incidence and
prevalence of idiopathic, usually immunologically mediated,
glomerular disease is required.
Renal biopsy studies -suggest wide differences in the inci-
dence of immunologically mediated, idiopathic glomerular dis-
ease between various human races, in Caucasians between
continents, or within one continent between various countries
[1—3]. These observed differences in incidence should be inter-
preted with caution, since they may be influenced by screening
procedures for detecting asymptomatic patients, selective re-
ferral of patients with progressive renal disease to nephrological
centers and indication for renal biopsy. Chronic sclerosing
glomerular disease, for example, represents a variable, though
important percentage of biopsied patients in studies given
prevalence of glomerular disease [4].
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In this study the incidence of idiopathic glomerular disease in
adults was determined by means of renal biopsies taken early in
the natural history of disease in a prospective regional study.
Renal biopsies were taken on strict indications and contraindi-
cations. The design of the study avoided referral to nephrologi-
cal centers, while the organization of the local primary health
care insured stable populations serviced by the three participat-
ing city hospitals in an adjoining circumscript area, thus en-
abling us to estimate incidence figures for idiopathic glomerular
disease.
Methods
Patients
In this study (absolute) indications for percutaneous renal
biopsy were: recent onset uremia (serum creatinine concentra-
tion >300 jsmol/liter), and recent onset nephrotic syndrome (24
hours proteinuria> 5 g in the absence of Bence Jones protein-
uria) of unknown origin. In the context of this study, recent
onset implied that the renal biopsy had to be taken within six
months after discovery of signs and symptoms of renal disease.
Other indications were persisting idiopathic erythrocyturia or
recurrent macroscopic hematuria with or without significant
proteinuria (24 h proteinuria > 0.5 g but < 5 g) of at least half
a year duration, in the presence of a normal urologic workup,
and chronic idiopathic proteinuria (24 h proteinuria > 0.5 g) of
at least half a year duration in the absence of chronic hyperten-
sion. Prior to renal biopsy 24 hour urine was collected and
protein quantitated by the Biuret method; adequacy of the urine
collection was verified by measuring the creatinine excretion.
Contraindications for renal biopsy included the absence of
one kidney, coagulation disorders and angiographically—pi-oven
polyarteritis nodosa. Relative contraindications for renal biopsy
were acute tubular necrosis, urinary tract infections or urologi-
cal abnormalities. Acute postinfectious glomerulonephritis was
no indication for renal biopsy unless proteinuria and hematuria
persisted.
Excluded from the study were patients biopsied because of
signs of renal disease in known systemic disease (inclusive
diabetes mellitus, cirrhosis of the liver, ankylosing spondylitis,
multiple myeloma and generalized atherosclerosis), patients
with drug—associated disease, patients with chronic hyperten-
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sion and patients deriving from known Alport families. Also
excluded were patients biopsied because of chronic hematuria
or proteinuria known longer than two years, children less than
16 years of age and adults over 65 years of age.
Routine laboratory tests at the time of the renal biopsy
included antinuclear and rheumatoid factors, cryoglobulins,
anti-streptolysin titers, classical hemolytic complement activity
and liver function tests.
Nephritic factor was determined by Dr. M,H. Daha, Renal
Unit Leiden University hospital, The Netherlands. Antiglo-
merular basalmembrane antibodies were determined by Dr. P.
Mahieu, Renal Unit, University of Liege, Belgium.
The renal biopsies
Renal biopsy specimens were processed and stained for light
microscopy, transmission electron microscopy and immunohis-
tochemistry using polyclonal antisera against human IgG, 1gM,
IgA, C3, Clq, kappa and lambda light chains as described
previously [5]. All biopsies from patients with idiopathic IgA
nephropathy stained in the indirect immunofluorescence invari-
ably with monoclonal anti-IgA1-, and in two also with mono-
clonal anti-IgA2 antibodies.
Of the membranous glomerulopathies all sections were
stained in the indirect immunoperoxidase technique with a
polyclonal anti-HBe antiserum. Hepatitis Be antigen had to be
absent from the glomeruli for the membranous glomerulopathy
to be called idiopathic.
All biopsies taken because of hematuria, hematuria and
proteinuria and nephrotic syndrome were examined ultrastruc-
turally. Normal adult glomerular basal membrane thickness in
our laboratory (N = 30) measures 350 60 nm [6, 7]; a
thickness less than 230 nm seen in multiple glomerular loops
was considered diagnostic for the presence of thin glomerular
basal membranes 18].
Biopsies containing less than 5 glomeruli per 2 i section were
classified as technical failures.
Renal biopsies were classified according to the WHO criteria
[9, 10]. Renal disease was considered idiopathic when extrare-
nal systemic disease was absent at the time of renal biopsy and
did not develop within one year of follow—up.
Estimation of incidence of disease
Biopsies were taken in the city hospitals of Heerlen,
Maastricht and Sittard, all direct referral hospitals for the
general practitioners, with an adherent population of 135,000,
85,000 and 90,000 adults (16 to 65 years of age), respectively.
The adherent population of a hospital is defined as the popula-
tion served by general practitioners, who refer their patients to
that hospital. The adherent population for each hospital was
determined by the "Medisch en Maatschappelijk Informatie
Centrum" at Maastricht halfway during the study (1980) for
each participating hospital. This adherent population was
worked with, since this part of the Netherlands has a stable
population in terms of migratory behaviour and referral pattern.
In multiplying the number of years of participation in the study
with its adherent population, the total population from which
the patients were derived was calculated for each hospital. In
each hospital, renal biopsies were taken systematically for the
number of years required for an adherent population of about
500,000.
Table 1. Indications for renal biopsy per hospital
City
hospital
No. of
years
No.
biopsies
Indication
biopsya
for Total adherent
population per
hospitaV'H H&P P NS U
Heerlen
Maastricht
Sittard
4
6
5
51
78
60
11
22
15
9 7
25 6
18 10
16
14
15
8
11
2
540,000
510,000
450,000
Total 189 48 52 23 45 21 1,500,000
Abbreviations are: H, chronic hematuria without proteinuria; H&P,
chronic hematuria with proteinuria; P, chronic proteinuria; NS, ne-
phrotic syndrome; U, uremia.b Number of adult patients between 16 and 65 years of age serviced
by a given city hospital x the numbers of years of participation in the
study.
Statistical inferences were made by using the normal approx-
imation to the binomial distribution, and a probability of less
than 1% was assumed to be significant.
Results
Indications for renal biopsy and adherent population
From 1978 to 1984, 189 renal biopsies were taken from the
city hospitals of Heerlen, Sittard and Maastricht, during four,
five and six years, respectively, because of signs and symptoms
of suspected idiopathic renal—disease. The indication for renal
biopsy is given in a hierarchical order; uremia, nephrotic
syndrome, hematuria with proteinuna, chronic hematuria and
chronic proteinuria. The total adherent population from which
these biopsies derived was 1.5 million (Table 1). Over the years,
the number of patients entering the study annually per hospital
was constant and no change in indication was observed. In
patients with uremia or nephrotic syndrome, the renal biopsy
was taken within three months (mean) after detection of dis-
ease. In patients with chronic hematuria or proteinuria a biopsy
was performed one year (mean) after referral to the nephrolo-
gist.
Incidence of idiopathic glomerular disease
The incidence of idiopathic glomerular disease related to the
indication for renal biopsy is given in Table 2. Of the 189
patients clinically suspected of having idiopathic glomerular
disease, 12 were shown to have systemic disease at the time of
renal biopsy (N = 10) or during follow—up (N = 2); seven
patients showed renal athero- and arterioloscierosis, and from
27 patients normal renal tissue was obtained. In 14 patients,
material was insufficient for diagnosis. Thus 129 instances of
idiopathic renal disease were diagnosed in a total population at
risk of 1.5 million adults.
When the hospitals were compared with one another, signif-
icantly less patients were biopsied in Heerlen because of
chronic hematuria and chronic hematuria with proteinuria.
When these differences in indication were related to the inci-
dence of idiopathic glomerular disease, the only significant
difference found was a greater incidence of thin glomerular
basal membrane lesions in Maastricht and Sittard, compared to
Heerlen. Also, compared to Heerlen, Maastricht and Sittard
biopsied a greater number of patients from which normal renal
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Table 2. Incidence of idiopathic renal disease related to indication for renal biopsy
tissue was obtained. The incidence of IgA nephropathy in the
adherent populations of the three hospitals did not differ.
Clinically, the 29 patients with IgA nephropathy could be
subdivided into two subsets; those patients biopsied because of
recurrent macroscopic (N 10) or persisting microscopic
hematuria (N = 18); the remaining patient was biopsied because
of recent onset nephrotic syndrome. Thus the incidence of
idiopathic IgA nephropathy was 19 per million adults per year;
the prevalence of this disease in patients biopsied because of
idiopathic recurrent macroscopic or persistent microscopic
hematuria was 36 and 29%, respectively (Table 3).
No differences were observed between the hospitals in the
number of renal biopsies taken because of chronic proteinuria
or recent onset nephrotic syndrome, and the various subsets
were equally distributed over the hospitals.
Morphologically characteristic lesions of membranoprolifera-
tive glomerulonephritis were seen in two patients biopsied
because of nephrotic syndrome, making the incidence of this
disease less than two per million per year in adults. In addition,
three patients admitted with acute azotemic glomerulonephritis
after an upper respiratory tract infection, judged to be of viral
origin on clinical grounds, remained proteinuric after remission
of the acute episode, and subsequently developed nephrotic
syndrome with normalization of renal function. Renal biopsies
taken at this time showed morphological changes of acute
Indication for No.
Normal
renal
Thin
GBM
Idiopathic
IgA
renal biopsy patients tissue lesions nephropathy Divers
a Ofat least 0.5 year but less than 2 years duration in the presence of
a normal urologic workup
glomerulonephritis, with diffuse endocapillary cell prolifera-
tion, margination of esterase positive cells in the glomerular
capillaries without basal membrane changes, and ultrastruc-
No.
biopsies
6Incidence per 10
adults per year
Indication for renal biopsya
H H&P H&P/U P NS U
Idiopathic renal disease
29 19 9 18 1 1 —IgA nephropathy —
Foc.segm.prolif.extracap. GNb 3 — — — — 1 2
Diff.segm.prolif.extracap. GNC 7 7
Membranoprolif.GN, type 1 2 — — — — 2
Membranous glomerulopathy 14 9 — — — — 14 —
Diffuse scierosing GN 5 — — — — — 5
Other proliferative GN
idiopathic 9 — 6 — — 3 —
postinfectiousd 8 — 2 2 4
Minimal change glomerulopathy 9 6 — — — — 9
Thin GBM lesions 19 13 12 7 — — — —
Interstitial nephritis 7 3 — 2' — l I
Focal segm. glomerular sclerosis and
hyalinosis 14 9 — 1 — 7 6 —
Focal global glomerular sclerosis 3 1 2 — — — —
Secundary renal disease
Systemic diseasee not suspected or
known prior to renal biopsy 12 — 1 — 2 3 6
Renal arterio- and arteriolo-scierosis;
no clinical evidence of systemic
atherosclerosis or hypertension 7 — — — 7 — —
Normal renal tissue 27 17 7 — 3 —
Technical failures 14 6 2 1 4 1 —
a Abbreviations are: H, chronic hematuria without proteinuria; H&P, chronic hematuria with proteinuria; H&P/U, hematuria with proteinuria
and serum creatinine over 120 prnol/liter; P, chronic proteinuria; NS, nephrotic syndrome; U, serum creatinine over 300 mol/liter.' Focal (less than 70% of all glomeruli), segmental extracapillary proliferative lesions
Diffuse (over 70% of all glomeruli), segmental extracapillary proliferative lesions; 4 x anti-glomerular basal membrane glomerulonephritisd Persisting symptoms of acute glomerulonephritis after poststreptococcal (1 patient) and postviral (7 patients) upper respiratory tract infections
Fibrinoid necrosis of the afferent arterioles (essential hypertension, 2 patients), polyarteritis nodosa (1), light chain disease (1), benign
monoclonal gammopathy (1), subacute bacterial endocarditis (I), membranous glomerulopathy (2) associated with hepatitis B (e antigen) or
bronchial carcinoma, IgA nephropathy and cirrhosis of the liver (1), amyloid (1) and minimal change glomerulopathy (2) (after gold therapy for
rheumatoid arthritis (I), and Diclofenac medication (1).
Chronic interstitial nephntis and focal segmental glomerulosclerosis and hyalinosis.
Table 3. Renal biopsy findings in patients presenting with
chronic non-azotemic hematuriaa
Recurrent macroscopic
hematuria
24 hours urinary
protein
<500 mg
24 hours urinary
protein
>500 mg by <5 g
Persistent erythro-
cyturia
24 hours urinary
protein
<500 mg
24 hours urinary
protein
>500 mg but <5 g
Total no. patients
14 9 1 4
14 5 — 6 3
28 8 11 5 4
32 2 7 12 Il
88 24 19 27 18
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turally—scattered subepithelial electron—dense deposits. These
patients were again biopsied during follow—up because of
persisting nephrotic syndrome. Now changes of membrano-
proliferative glomerulonephritis (type I, N = 2 and type III, N
= 1) had developed. None of these patients showed hypocom-
plementemia or nephritic factor at the time of renal biopsy or
during two years of follow—up. Of the 21 patients with recent
onset uremia, significantly less patients were biopsied at Sittard
hospital compared with Maastricht, for reasons unknown.
Discussion
Estimates on incidence of idiopathic glomerular disease re-
quire morphological characterization of signs and symptoms of
renal disease. Consequently, these estimates are influenced by
a "detection threshold" of signs and symptoms of disease,
referral patterns, and indication for renal biopsy. In this study
the indication for renal biopsy was controlled and a center effect
was avoided, but detection and referral to the local nephrologist
were not controlled. The Dutch Health Care delivery insures
that adults with macroscopic hematuria, symptomatic nephrotic
syndrome or uremia will be detected and referred to the local
hospital. This reasoning does not hold necessarily for asymp-
tomatic adults with chronic erythrocyturia or proteinuria in the
absence of (chronic) hypertension; thus the incidence estimates
of some glomerular diseases, such as thin glomerular basal
membrane lesions and focal segmental glomeruloscierosis and
hyalinosis, are probably too low. The same reasoning holds a
priori for idiopathic IgA nephropathy, but our results do not
bear this out. The incidence of this disease was comparable for
each hospital, although the prevalence of IgA nephropathy in
the patients biopsied because of recurrent macroscopic
hematuria and microscopic erythrocyturia varied markedly per
hospital, from 29% to 41%. This observation suggests that
patients with IgA nephropathy presenting with hematuria, who
are usually male [11] and proteinuric (Table 3), are both
detected and referred for renal biopsy, in contrast for example,
to patients with thin glomerular, basal membrane lesions, a
disease equally distributed in our study between the sexes and
usually not associated with macroscopic hematuria or signifi-
cant proteinuria (Table 3). Interestingly a comparable incidence
of idiopathic IgA nephropathy, 25 per 106 inhabitants, was
recently reported from a regional, but not age restricted, study
in France [12]. These results suggest that the differences in
prevalence of IgA nephropathy, when expressed as percentages
of the total biopsy material, of 1.5% in the USA [13], 4% in the
United Kingdom [14], 5% in the Netherlands [15] and 22% in
France [16], do not reflect differing incidences of IgA nephrop-
athy, but rather differences in referral and indication for renal
biopsy, which is not specified in these studies. Whether the
very high prevalence of IgA nephropathy in Japan [17] of 40%
and Singapore of 56% [18], when expressed in percentages of
total biopsy material, is caused by a true higher incidence of
idiopathic IgA nephropathy, is not clear.
Of the 19 patients biopsied because of chronic proteinuria,
the prevalence of renal atherosclerosis and vascular hyalinosis,
and focal segmental glomerulosclerosis and hyalinosis was an
equal 37%. Others too have described renovascular hyalinosis
in normotensive patients with isolated proteinuria in the ab-
sence of diabetes mellitus and have suggested that these lesions
may precede hypertension rather than be caused by it [19]. Of
the seven patients with focal and segmental glomerulosclerosis
and hyalinosis, the chronic proteinuria was associated with a
decreased renal function in one patient with unilateral renal
agenesis in situs inversus; the others had normal creatinine
clearances and no hypertension or nephrotic syndrome in the
past history. This observation suggests the existence of an
idiopathic form of focal and segmental glomerulosclerosis and
hyalinosis, different from the lesions observed in conditions of
glomerular hyperfiltration due to nephrotic syndrome or re-
duced functional renal mass [20]. Similar observations have
been made in inbred rat strains, in which susceptibility to focal
segmental glomeruloscierosis and hyalinosis appears to be
genetically determined [21].
In this study the incidence of idiopathic nephrotic syndrome
was 27 per 106 adults per year with prevalence rates of id-
iopathic membranous glomerulopathy stage I to II, minimal
change glomerulopathy, focal segmental glomeruloscierosis and
membranoproliferative glomerulonephritis type 1 of 34%, 22%,
15% and 5%, respectively. This prevalence of membranous
glomerulopathy is in the same order of that as found in series
from the USA [22] or the United Kingdom [231 in patients
biopsied because of nephrotic syndrome in the 1970 to 1978
period. The prevalence of membranoproliferative glomerulone-
phritis in patients biopsied because of idiopathic nephrotic
syndrome of 5% is less than the 12% reported from the USA
[22], the 8% reported from the UK [23] or the 18% reported
from the Netherlands in the period 1957 to 1975 [24]. The low
prevalence of membranoproliferative glomerulonephritis may
be due to three, not mutually exclusive causes. First, in
preliminary data from a multicenter study in Northern Italy, a
significant decrease in the prevalence of membranoproliferative
glomerulonephritis type I was described in patients biopsied
over the period 1972 to 1983 [25]; a similar trend may hold for
the Netherlands. Next classical membranoproliferative glomer-
ulonephritis with hypocompementemia and the presence of
nephritic factor is mainly a disease of children and teenagers
[26]; the design of our study excluded these patients. Finally it
is a matter of personal philosophy whether or not one considers
those patients who developed membranoproliferative glomeru-
lonephritis after an episode of acute glomerulonephritis would
suffer from acute onset membranoproliferative glomerulone-
phritis or—as our clinical observations suggest—would suffer
from an undefined, possibly autoimmune, reaction secondary to
acute (postviral) glomerulonephritis. In the former view the
prevalence of membranoproliferative glomerulonephritis would
be 12% of the idiopathic nephrotic syndromes.
Of the 16 patients presenting with recently discovered uremia
due to idiopathic renal disease, nine showed extracapillary
crescentic glomerulonephritis of the focal (N = 2) or diffuse(N = 7) variety; the latter was in four patients mediated by
anti-GBM antibodies. A surprisingly high prevalence (25%) of
diffuse sclerosing glomerulonephritis was found. Whether these
lesions represent chronic, clinically silent and undetected gb-
merulonephritis or a scierosing variety of rapidly progressive
gbomerubonephritis remains uncertain.
In conclusion, the main findings of this study are fourfold.
First of the idiopathic renal diseases the incidence of IgA
nephropathy, Berger's type, is the highest at 19 per 106 adults
per year, as is the prevalence of this disease in patients biopsied
because of chronic non-azotemic microscopic or recurrent
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macroscopic hematuria. Second, the incidence of focal segmen-
tal glomerulosclerosis and hyalinosis is high, as is the preva-
lence in patients presenting with chronic proteinuria and
nephrotic syndrome. Next the incidence of membranoprolifera-
tive glomerulonephntis is low as is the prevalence in patients
biopsied because of recently discovered nephrotic syndrome.
Finally the prevalence of diffuse sclerosing glomerulonephritis
in patients biopsied because of recently discovered uremia is
high, although the incidence is low.
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